Portal Biotech

Portal Biotech is a pioneering biotechnology company developing the world's first bench-top single-molecule protein sequencer. By leveraging proprietary nanopore technology and advanced machine learning algorithms, the company enables rapid, full-length protein characterization, providing insights into protein identity, abundance, and structure that traditional mass spectrometry cannot match. The company's platform is designed to support a wide range of applications, including drug discovery, precision medicine, and global biosecurity. Headquartered in London with operations in Groningen, Portal Biotech aims to transform proteomics by bringing high-precision molecular analysis out of specialized labs and into everyday research and diagnostic workflows.